Icos shareholders approve Lilly acquisition offer
Shareholders of Icos Corp. voted 77 percent to 33 percent today to accept Eli Lilly and Co.’s $2.3 billion offer for the developer of the erectile dysfunction drug Cialis, according to Bloomberg. Analysts quoted by Bloomberg said shareholders were so divided about the deal that they couldn’t predict whether Lilly would succeed. Only three […]